UAB’s Jack Hasson has been named the 2017 Outstanding Clinician by the American Thoracic Society.
Three UAB investigators have received innovative research grants for lung diseases from the National Institutes of Health.
Massoud Leesar, M.D., performed the first procedure Jan. 25, 2017, and that is good news for people who suffer strokes as a result of patent foramen ovale, or PFO.
Research from UAB suggests that nearly half of children with the most common type of leukemia or their parents say they took more medications than they actually did.
UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
UAB’s innovative Patient Care Connect Program utilizes lay navigation and provides a cost-effective new model for cancer care delivery.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
Five faculty members in the School of Medicine have been named the 2016 class of James A. Pittman Jr., M.D., Scholars, a program organized to recognize the contributions of junior faculty and support the retention of highly competitive scientists and physician-scientists.
The new UAB Integrative Medicine Clinic will provide conventional medical care with complementary approaches to tackle the biological, social and spiritual aspects of health and illness.
Page 5 of 32